This study aims to propose a fully automatic approach based on convolutional neural networks (CNNs) to predict the O6-Methylguanine-DNA-methyltransferase (MGMT) methylation status of gliomas using conventional pre-operative MR images. It was shown that the Markov Random Field-U-Net network can accurately segment the tumor region, and the improved 34-layer Resnet network can predict the MGMT methylation status effectively. This model has the potential to be a practical tool for the non-invasive characterization of gliomas to help the individualized treatment planning.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: